Literature DB >> 2733381

Timing of intake of lipid lowering drugs: is that of importance?

M Hanefeld1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2733381     DOI： 10.1007/bf01721679

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  5 in total

1.  Mevalonic acid in human plasma: relationship of concentration and circadian rhythm to cholesterol synthesis rates in man.

Authors:  T S Parker; D J McNamara; C Brown; O Garrigan; R Kolb; H Batwin; E H Ahrens
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

2.  Effect of time of administration of cholestyramine on plasma lipids and lipoproteins.

Authors:  J R Peters; D B Hunninghake
Journal:  Artery       Date:  1985

3.  Comparative efficacy of once versus twice daily mevinolin in the therapy of familial hypercholesterolemia.

Authors:  D R Illingworth
Journal:  Clin Pharmacol Ther       Date:  1986-09       Impact factor: 6.875

4.  A steady-state evaluation of the effects of propantheline bromide and cholestyramine on the bioavailability of digoxin when administered as tablets or capsules.

Authors:  D D Brown; J Schmid; R A Long; J H Hull
Journal:  J Clin Pharmacol       Date:  1985 Jul-Aug       Impact factor: 3.126

5.  Stimulatory effect of dietary lipid and cholestyramine on hepatic HMG CoA reductase.

Authors:  S Goldfarb; H C Pitot
Journal:  J Lipid Res       Date:  1972-11       Impact factor: 5.922
  5 in total
  1 in total

1.  Actual versus prescribed timing of lovastatin doses assessed by electronic compliance monitoring.

Authors:  W Kruse; T Nikolaus; J Rampmaier; E Weber; G Schlierf
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.